en

PRODUCT DETAIL

DALMEVIN 50 mg tablety

Code 5756C
MA number 18/0335/17-S
Product Form: tbl 60x50 mg (blis.Al/Al)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 18 - ANTIDIABETICA (VRÁTANE INZULÍNU)
ATC:
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B Blood glucose lowering drugs, excl. insulins
A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
A10BH02 Vildagliptin
Shelf life: 36
Container: blister Al/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 14.11.2017
PIL: PIL_DALMEVIN 50 mg tablety_10.2023.pdf  
SPC: SPC_DALMEVIN 50 mg tablety_10.2023.pdf  
Safety feature Yes
Data update: 01.12.2022
eu-flag.png sk-flag.png